{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:48:22Z","timestamp":1793908102097,"version":"4.8.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>Gouty arthritis (GA) is an inflammatory disease primarily triggered by the deposition of monosodium urate (MSU) crystals in and around the joints. With rising living standards and shifts in dietary patterns, the global incidence of GA is increasing, accompanied by a trend toward earlier onset. Consequently, elucidating its pathogenesis and developing effective treatments are major priorities in clinical research. Animal models of GA serve as an indispensable platform for mechanistic investigation and therapeutic development, especially for novel pharmacological agents. Current animal models of GA are broadly categorized into three types: MSU crystal-induced acute inflammation models, hyperuricemia-combined models, and those designed to simulate chronic gout and tophus formation. While existing approaches successfully replicate the acute inflammatory response characteristic of GA, they remain substantially limited in recapitulating the key features of the chronic disease phase, notably spontaneous tophus formation and persistent synovitis. This article critically examines the defining characteristics and optimal applications of prevailing GA models and proposes targeted strategies for their future optimization.<\/jats:p>","DOI":"10.3389\/fvets.2026.1785462","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T14:58:21Z","timestamp":1775141901000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Gouty arthritis animal models: limitations, challenges, and optimization strategies"],"prefix":"10.3389","volume":"13","author":[{"given":"Huan","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Spinal Orthopedics, Guangdong Provincial Second Hospital of Traditional Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Spinal Orthopedics, Guangdong Provincial Second Hospital of Traditional Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[{"name":"The Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine","place":["Foshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","article-title":"Inflammation in gout: mechanisms and therapeutic targets","volume":"13","author":"So","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/RHU.0b013e31827d8790","article-title":"Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis. JCR","volume":"19","author":"Cronstein","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/rheumatology\/ket265","article-title":"Health-related quality of life in gout: a systematic review","volume":"52","author":"Chandratre","year":"2013","journal-title":"Rheumatology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.3969\/j.issn.2095-4344.2017.24.019","article-title":"A modified rabbit model of gouty knee arthritis","volume":"21","author":"Li","year":"2017","journal-title":"Zhongguo Zu Zhi Gong Cheng Yan Jiu"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13075-015-0550-4","article-title":"Animal model of acute gout reproduces the inflammatory and ultrasonographic joint changes of human gout","volume":"17","author":"Pineda","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0304-3959(87)90072-8","article-title":"Ankle joint urate arthritis (AJUA) in rats: an alternative animal model of arthritis to that produced by Freund's adjuvant","volume":"28","author":"Coderre","year":"1987","journal-title":"Pain"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1097\/01.lab.0000029206.27080.d2","article-title":"Involvement of CXC chemokine growth-related oncogene-\u03b1 in monosodium urate crystal-induced arthritis in rabbits","volume":"82","author":"Fujiwara","year":"2002","journal-title":"Lab Investig"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/art.10326","article-title":"Monosodium urate monohydrate crystal\u2013induced inflammation in vivo: quantitative histomorphometric analysis of cellular events","volume":"46","author":"Schiltz","year":"2002","journal-title":"Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1002\/art.11079","article-title":"Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis","volume":"48","author":"Ryckman","year":"2003","journal-title":"Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1136\/ard.2009.108936","article-title":"The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study","volume":"68","author":"Terkeltaub","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1136\/ard.2010.128454","article-title":"The pathogenesis of bone erosions in gouty arthritis","volume":"69","author":"Schlesinger","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s10067-020-05090-8","article-title":"Gout: a disease involved with complicated immunoinflammatory responses: a narrative review","volume":"39","author":"Wu","year":"2020","journal-title":"Clin Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00011-013-0615-2","article-title":"Anti-nociceptive and anti-edematogenic effects of glibenclamide in a model of acute gouty attack in rats","volume":"62","author":"Dos Santos","year":"2013","journal-title":"Inflamm Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"9398435","DOI":"10.1155\/2016\/9398435","article-title":"Therapeutic effects of Chinese medicine herb pair, Huzhang and Guizhi, on monosodium urate crystal-induced gouty arthritis in rats revealed by anti-inflammatory assessments and NMR-based Metabonomics","volume":"2016","author":"Han","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e003499","DOI":"10.1136\/rmdopen-2023-003499","article-title":"New animal model of chronic gout reproduces pathological features of the disease in humans","volume":"9","author":"Wang","year":"2023","journal-title":"RMD Open"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1470380","DOI":"10.1155\/2021\/1470380","article-title":"The role of oxidative stress in hyperuricemia and xanthine oxidoreductase (XOR) inhibitors","volume":"2021","author":"Liu","year":"2021","journal-title":"Oxidative Med Cell Longev"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/rheumatology\/keg305","article-title":"Intra-articular corticosteroid preparations: different characteristics and their effect during inflammation induced by monosodium urate crystals in the rat subcutaneous air pouch","volume":"42","author":"Rull","year":"2003","journal-title":"Rheumatology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1136\/ard.2009.109355","article-title":"Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis","volume":"68","author":"Torres","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3390\/ijms21062147","article-title":"High-protein diet induces hyperuricemia in a new animal model for studying human gout","volume":"21","author":"Hong","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1074867","DOI":"10.3389\/fimmu.2022.1074867","article-title":"Overnutrition-induced gout: an immune response to NLRP3 inflammasome dysregulation by XOD activity increased in quail","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1073\/pnas.91.2.742","article-title":"Hyperuricemia and urate nephropathy in urate oxidase-deficient mice","volume":"91","author":"Wu","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.kint.2017.04.031","article-title":"Knockout of the urate oxidase gene provides a stable mouse model of hyperuricemia associated with metabolic disorders","volume":"93","author":"Lu","year":"2018","journal-title":"Kidney Int"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/15257770.2016.1143559","article-title":"Urat1-Uox double knockout mice are experimental animal models of renal hypouricemia and exercise-induced acute kidney injury","volume":"35","author":"Hosoyamada","year":"2016","journal-title":"Nucleosides Nucleotides Nucleic Acids"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1785462\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T14:58:23Z","timestamp":1775141903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1785462\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":25,"alternative-id":["10.3389\/fvets.2026.1785462"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2026.1785462","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"article-number":"1785462"}}